Latest other assets for REPH: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Recro Pharma (REPH) currently reports a other assets of $0 as of December 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Recro Pharma's other assets history and peer comparisons.
Recro Pharma's other assets changed from $0 to $0 (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Recro Pharma reported $0 in other assets as of December 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Recro Pharma, and consider following REPH for alerts when major investors trade the stock.
Recro Pharma is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REPH with unrelated industries.